Opexa (OPXA) Developing MS Treatment in Partnership with Merck Serono – Video

Posted: Published on July 1st, 2014

This post was added by Dr Simmons




Opexa (OPXA) Developing MS Treatment in Partnership with Merck Serono
Host Dave Gentry interviews Neil Warma, CEO of Opexa Therapeutics (Nasdaq: OPXA), a biotechnology company developing Tcelna, a novel T-cell immunotherapy for the treatment of multiple sclerosis...

By: RedChip Money Report Gentry

More:
Opexa (OPXA) Developing MS Treatment in Partnership with Merck Serono - Video

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.